S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
Log in

Oncomed Pharmaceuticals News Headlines (NASDAQ:OMED)

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.89
0.00 (0.00 %)
(As of 01/22/2020 01:09 PM ET)
Today's Range
$0.89
Now: $0.89
$0.89
50-Day Range
$0.89
MA: $0.89
$0.89
52-Week Range
$0.55
Now: $0.89
$3.35
VolumeN/A
Average Volume768,904 shs
Market Capitalization$34.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Oncomed Pharmaceuticals (NASDAQ OMED) News Headlines

Source:
DateHeadline
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for NavicixizumabMereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
www.prnewswire.com - January 13 at 1:00 PM
Mereo BioPharmas (MREO) CEO Denise Scots-Knight on 2019 Interim Financial Results and Corporate Update Conference CallMereo BioPharma's (MREO) CEO Denise Scots-Knight on 2019 Interim Financial Results and Corporate Update Conference Call
seekingalpha.com - September 17 at 5:35 PM
Mereo BioPharma Loss Narrows On Gain From OncoMed Buy And ExpensesMereo BioPharma Loss Narrows On Gain From OncoMed Buy And Expenses
www.morningstar.co.uk - September 17 at 9:28 AM
Cancer Stem Cells Market: Comprehensive study explores Huge Growth in FutureCancer Stem Cells Market: Comprehensive study explores Huge Growth in Future
www.marketwatch.com - August 21 at 10:13 AM
Cancer Stem Cell Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2023Cancer Stem Cell Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2023
www.marketwatch.com - August 13 at 9:49 PM
ViaCyte to Expand Board of Directors with Two New AppointmentsViaCyte to Expand Board of Directors with Two New Appointments
www.marketwatch.com - July 24 at 11:59 AM
Cancer Stem Cell: The Next Booming Market in the World| MacroGenics, OncoMed Pharmaceuticals, STEMCELL TechnologiesCancer Stem Cell: The Next Booming Market in the World| MacroGenics, OncoMed Pharmaceuticals, STEMCELL Technologies
www.marketwatch.com - May 16 at 8:51 AM
Amunix Expands Executive Team with Appointment of Dr. Mika Derynck as CMO, Dr. Darcy Mootz as CBO, and Yvonne Li as SVP of FinanceAmunix Expands Executive Team with Appointment of Dr. Mika Derynck as CMO, Dr. Darcy Mootz as CBO, and Yvonne Li as SVP of Finance
www.globenewswire.com - May 14 at 11:41 AM
Citi Appointed as Depositary Bank for Mereo BioPharma’s ADR ProgrammeCiti Appointed as Depositary Bank for Mereo BioPharma’s ADR Programme
www.marketwatch.com - April 24 at 11:16 AM
Mereo BioPharma Completes Merger With OncoMed PharmaceuticalsMereo BioPharma Completes Merger With OncoMed Pharmaceuticals
www.morningstar.co.uk - April 23 at 11:02 AM
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.
finance.yahoo.com - April 23 at 11:02 AM
OncoMed Shareholders Approve All-Share Merger With Mereo BioPharmaOncoMed Shareholders Approve All-Share Merger With Mereo BioPharma
www.lse.co.uk - April 18 at 11:37 AM
Mereo BioPharma Scures Further Acceptances From OncoMed ShareholdersMereo BioPharma Scures Further Acceptances From OncoMed Shareholders
www.morningstar.co.uk - March 15 at 4:19 PM
OncoMed declares one-time contractual right dividend; shares up 7% premarketOncoMed declares one-time contractual right dividend; shares up 7% premarket
seekingalpha.com - March 15 at 11:55 AM
OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value RightsOncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights
finance.yahoo.com - March 15 at 11:55 AM
OncoMed Announces Fourth Quarter and Full Year 2018 Financial ResultsOncoMed Announces Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 7 at 4:19 PM
Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)
www.morningstar.co.uk - February 22 at 12:37 PM
Mereo BioPharma Founding Director Departs Before OncoMed CombinationMereo BioPharma Founding Director Departs Before OncoMed Combination
www.morningstar.co.uk - February 11 at 8:45 AM
Mereo Publicly Files Registration Statement on Form F-4 with U.S. Securities and Exchange Commission - GlobeNewswireMereo Publicly Files Registration Statement on Form F-4 with U.S. Securities and Exchange Commission - GlobeNewswire
www.globenewswire.com - January 25 at 10:37 AM
Gossamer Bio Announces Appointment of Jakob Dupont, M.D. as Chief Medical OfficerGossamer Bio Announces Appointment of Jakob Dupont, M.D. as Chief Medical Officer
www.businesswire.com - December 17 at 3:59 PM
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel